neuropathic%20pain
NEUROPATHIC PAIN
Neuropathic pain is the sensation of pain due to abnormal discharges of impaired or injured neural structures in the peripheral &/or central nervous system.
It is characterized by hyperesthesia, hyperalgesia and allodynia.
Common neuropathic pain syndromes are central neuropathic pain, painful diabetic peripheral neuropathy, postherpetic neuralgia, trigeminal neuralgia, postsurgical neuropathic pain, HIV-related neuropathy, lumbosacral radiculopathy and complex regional pain syndrome.

Neuropathic%20pain Signs and Symptoms

Introduction

 Neuropathic pain

  • Pain arising as a consequence of a lesion or disease of the peripheral and/or central nervous system affecting the somatosensory system
  • Nerve conduction blockage causes nerve dysfunction, leading to numbness, weakness and loss of deep tendon reflexes in the area of involved nerve
  • Neuropathic conditions (eg brain infarction, spinal cord trauma, ischemic neuropathies) also cause aberrant symptoms of spontaneous and provoked pain

Pathophysiology

  •  Mechanisms involved in the pathophysiology of neuropathic pain:
    • At the neuroma site and along the length of the nerve after nerve injury there is proliferation of sodium channels that results to foci of ectopic activity that leads to spontaneous pain observed in patients with neuropathic pain
    • Sympathetic axons sprout around the dorsal root ganglion where the neuropathic pain is sympathetically mediated
    • Nerve injury diminishes the inhibitory control over dorsal horn neurons through various mechanisms
    • Central sensitization of the dorsal horn neurons manifested as a heightened response to noxious stimuli as well as pain associated with stimuli in the non-noxious range

Epidemiology

  • Prevalence of neuropathic pain varies due to its multiple etiologies and presentations
  • In Malaysia, the prevalence of neuropathic pain is estimated to range from 1.5% of the general population
    In Europe, it is estimated to afflict 7-8% of the general population
  • In studies using population-based questionnaires in Canada, it shows the prevalence as 4-8%
  • Diabetic polyneuropathy has been estimated to occur in 10-100% of diabetic patients in the Western world

Signs and Symptoms

  • Characterized by burning, stabbing and electrical pain which may be constant, aching or paroxysmal, pins and needles
  • Nerve conduction blockage causes nerve dysfunction, leading to numbness, weakness and loss of deep tendon reflexes in the area of involved nerve
Editor's Recommendations
Most Read Articles
01 Dec 2020
Tetanus toxoid 5 Lf, diphtheria toxoid 2 Lf, pertussis toxoid 2.5 mcg, filamentous haemagglutinin 5 mcg, fimbriae types 2 and 3 5 mcg, pertactin 3 mcg
Dr. Hsu Li Yang, Dr. Tan Thuan Tong, Dr. Andrea Kwa, 08 Jan 2021
Antimicrobial resistance has become increasingly dire as the rapid emergence of drug resistance, especially gram-negative pathogens, has outpaced the development of new antibiotics. At a recent virtual symposium, Dr Hsu Li Yang, Vice Dean (Global Health) and Programme Leader (Infectious Diseases), NUS Saw Swee Hock School of Public Health, presented epidemiological data on multidrug-resistant (MDR) gram-negative bacteria (GNB) in Asia, while Dr Tan Thuan Tong, Head and Senior Consultant, Department of Infectious Diseases, Singapore General Hospital (SGH), focused on the role of ceftazidime-avibactam in MDR GNB infections. Dr Andrea Kwa, Assistant Director of Research, Department of Pharmacy, SGH, joined the panel in an interactive fireside chat, to discuss challenges, practical considerations, and solutions in MDR gram-negative infections. This Pfizer-sponsored symposium was chaired by Dr Ng Shin Yi, Head and Senior Consultant of Surgical Intensive Care, SGH.
Jairia Dela Cruz, 5 days ago
Spending too much time sitting cannot be good for the body, and rising to one's feet breaks up such a behaviour and yields small, but meaningful, reductions in certain cardiovascular disease (CVD) risk factors, according to the results of a meta-analysis.
5 days ago
Use of thyroid hormone therapy does not seem to protect older adults with subclinical hypothyroidism against mortality, but it appears to confer survival benefits to those aged <65 years, results of a study have shown.